A citation-based method for searching scientific literature

Thomas A Fleisher, Joao Bosco Oliveira. Curr Opin Allergy Clin Immunol 2012
Times Cited: 13







List of co-cited articles
37 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
261
38

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
23

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010
78
23

Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study.
Alix E Seif, Catherine S Manno, Cecilia Sheen, Stephan A Grupp, David T Teachey. Blood 2010
52
23

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
149
23

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
79
23

Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Nina Lanzarotti, Bénédicte Neven, Cécile Daussy, Capucine Picard, Nathalie Neveux, Mukesh Desai, Meghana Rao, Kanjaksha Ghosh,[...]. J Allergy Clin Immunol 2013
28
23

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
78
23


A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Jack J H Bleesing, Margaret R Brown, Cynthia Novicio, David Guarraia, Janet K Dale, Stephen E Straus, Thomas A Fleisher. Clin Immunol 2002
57
15

Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells.
Karin Fischer, Simon Voelkl, Jana Heymann, Grzegorz K Przybylski, Krishna Mondal, Monika Laumer, Leoni Kunz-Schughart, Christian A Schmidt, Reinhard Andreesen, Andreas Mackensen. Blood 2005
171
15

Genetic disorders of programmed cell death in the immune system.
Nicolas Bidère, Helen C Su, Michael J Lenardo. Annu Rev Immunol 2006
138
15


Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.
Masatoshi Takagi, Kunihiro Shinoda, Jinhua Piao, Noriko Mitsuiki, Mari Takagi, Kazuyuki Matsuda, Hideki Muramatsu, Sayoko Doisaki, Masayuki Nagasawa, Tomohiro Morio,[...]. Blood 2011
85
15

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
15

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
Susan Price, Pamela A Shaw, Amy Seitz, Gyan Joshi, Joie Davis, Julie E Niemela, Katie Perkins, Ronald L Hornung, Les Folio, Philip S Rosenberg,[...]. Blood 2014
128
15

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
472
15

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
96
15

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Iusta Caminha, Thomas A Fleisher, Ronald L Hornung, Janet K Dale, Julie E Niemela, Susan Price, Joie Davis, Katie Perkins, Kennichi C Dowdell, Margaret R Brown,[...]. J Allergy Clin Immunol 2010
57
15

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
50
15

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis.
Julie E Niemela, Lianghao Lu, Thomas A Fleisher, Joie Davis, Iusta Caminha, Marc Natter, Laurel A Beer, Kennichi C Dowdell, Stefania Pittaluga, Mark Raffeld,[...]. Blood 2011
87
15

A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome.
Schafiq Nabhani, Andrea Hönscheid, Prasad T Oommen, Bernhard Fleckenstein, Jörg Schaper, Michaela Kuhlen, Hans-Jürgen Laws, Arndt Borkhardt, Ute Fischer. Clin Immunol 2014
17
15

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi,[...]. Blood 2011
89
15

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
15


Omenn syndrome: inflammation in leaky severe combined immunodeficiency.
Anna Villa, Luigi D Notarangelo, Chaim M Roifman. J Allergy Clin Immunol 2008
138
15

Reference intervals for serum IgG, IgA, IgM, C3, and C4 as determined by rate nephelometry.
C R Jolliff, K M Cost, P C Stivrins, P P Grossman, C R Nolte, S M Franco, K J Fijan, L L Fletcher, H C Shriner. Clin Chem 1982
111
15

Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.
William T Shearer, Howard M Rosenblatt, Rebecca S Gelman, Rebecca Oyomopito, Susan Plaeger, E Richard Stiehm, Diane W Wara, Steven D Douglas, Katherine Luzuriaga, Elizabeth J McFarland,[...]. J Allergy Clin Immunol 2003
561
15

B cell subsets in healthy children: reference values for evaluation of B cell maturation process in peripheral blood.
Barbara Piątosa, Beata Wolska-Kuśnierz, Małgorzata Pac, Katarzyna Siewiera, Ewa Gałkowska, Ewa Bernatowska. Cytometry B Clin Cytom 2010
98
15

Reference values for B cell subpopulations from infancy to adulthood.
H Morbach, E M Eichhorn, J G Liese, H J Girschick. Clin Exp Immunol 2010
234
15

Clinical and immunological overlap between autoimmune lymphoproliferative syndrome and common variable immunodeficiency.
A Rensing-Ehl, K Warnatz, S Fuchs, M Schlesier, U Salzer, R Draeger, I Bondzio, Y Joos, A Janda, M Gomes,[...]. Clin Immunol 2010
40
15

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
15

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.
Antonia Kwan, Roshini S Abraham, Robert Currier, Amy Brower, Karen Andruszewski, Jordan K Abbott, Mei Baker, Mark Ballow, Louis E Bartoshesky, Francisco A Bonilla,[...]. JAMA 2014
363
15

Practice parameter for the diagnosis and management of primary immunodeficiency.
Francisco A Bonilla, David A Khan, Zuhair K Ballas, Javier Chinen, Michael M Frank, Joyce T Hsu, Michael Keller, Lisa J Kobrynski, Hirsh D Komarow, Bruce Mazer,[...]. J Allergy Clin Immunol 2015
308
15

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease.
Sarah E Flanagan, Emma Haapaniemi, Mark A Russell, Richard Caswell, Hana Lango Allen, Elisa De Franco, Timothy J McDonald, Hanna Rajala, Anita Ramelius, John Barton,[...]. Nat Genet 2014
308
15

Human hyper-IgE syndrome: singular or plural?
Qian Zhang, Bertrand Boisson, Vivien Béziat, Anne Puel, Jean-Laurent Casanova. Mamm Genome 2018
40
15

Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification.
Aziz Bousfiha, Leila Jeddane, Capucine Picard, Waleed Al-Herz, Fatima Ailal, Talal Chatila, Charlotte Cunningham-Rundles, Amos Etzioni, Jose Luis Franco, Steven M Holland,[...]. J Clin Immunol 2020
279
15

Evidence for more than one Parkinson's disease-associated variant within the HLA region.
Erin M Hill-Burns, Stewart A Factor, Cyrus P Zabetian, Glenys Thomson, Haydeh Payami. PLoS One 2011
48
7

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
7

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.
Ashley D Reynolds, David K Stone, Jessica A L Hutter, Eric J Benner, R Lee Mosley, Howard E Gendelman. J Immunol 2010
244
7


Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.
E Farkas, G I De Jong, R A de Vos, E N Jansen Steur, P G Luiten. Acta Neuropathol 2000
150
7

Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.
Byoung Dae Lee, Joo-Ho Shin, Jackalina VanKampen, Leonard Petrucelli, Andrew B West, Han Seok Ko, Yun-Il Lee, Kathleen A Maguire-Zeiss, William J Bowers, Howard J Federoff,[...]. Nat Med 2010
274
7


Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.
Xian Lin, Loukia Parisiadou, Xing-Long Gu, Lizhen Wang, Hoon Shim, Lixin Sun, Chengsong Xie, Cai-Xia Long, Wan-Jou Yang, Jinhui Ding,[...]. Neuron 2009
359
7

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
Melissa K McCoy, Terina N Martinez, Kelly A Ruhn, David E Szymkowski, Christine G Smith, Barry R Botterman, Keith E Tansey, Malú G Tansey. J Neurosci 2006
262
7

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.
Ali Samii, Mahyar Etminan, Matthew O Wiens, Siavash Jafari. Drugs Aging 2009
106
7

Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease.
Valerio Pisani, Alessandro Stefani, Mariangela Pierantozzi, Silvia Natoli, Paolo Stanzione, Diego Franciotta, Antonio Pisani. J Neuroinflammation 2012
89
7


Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.
S O McGuire, Z D Ling, J W Lipton, C E Sortwell, T J Collier, P M Carvey. Exp Neurol 2001
181
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.